GeoVax Labs (GOVX) Enterprise Value Growth (5y) (2015 - 2026)
GeoVax Labs (GOVX) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.61% |
| Dec 31, 2025 | 20.77% |
| Sep 30, 2025 | 15.43% |
| Jun 30, 2025 | -34.20% |
| Mar 31, 2025 | -101.89% |
| Dec 31, 2024 | -81.02% |
| Sep 30, 2024 | -72.09% |
| Jun 30, 2024 | -48.48% |
| Mar 31, 2024 | -34.30% |
| Dec 31, 2023 | -90.13% |
| Sep 30, 2023 | -90.08% |
| Jun 30, 2023 | -147.65% |
| Mar 31, 2023 | -110.93% |
| Dec 31, 2022 | -145.01% |
| Sep 30, 2022 | -151.62% |
| Jun 30, 2022 | -106.52% |
| Mar 31, 2022 | -149.92% |
| Dec 31, 2021 | -90.61% |
| Sep 30, 2021 | -104.11% |
| Jun 30, 2021 | -146.40% |